HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Mueller-Brand Selected Research

(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)

12/2008Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.
4/2002Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study.
6/2001Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using.
4/2001A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


J Mueller-Brand Research Topics

Disease

3Neoplasms (Cancer)
12/2008 - 01/2003
2Glioma (Gliomas)
01/2003 - 04/2002
1Pheochromocytoma
12/2008
1Paraganglioma (Paragangliomas)
12/2008
1Merkel Cell Carcinoma
01/2004
1Astrocytoma (Pilocytic Astrocytoma)
04/2002
1Pain (Aches)
07/2001
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2001
1Malignant Carcinoid Syndrome
07/2001
1Coronary Disease (Coronary Heart Disease)
07/2001
1Thyroid Neoplasms (Thyroid Cancer)
06/2001
1Carcinoma (Carcinomatosis)
06/2001
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2001
1Renal Insufficiency (Renal Failure)
04/2001
1Thrombotic Microangiopathies
04/2001
1Chronic Renal Insufficiency
04/2001
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2001
1Pulmonary Embolism
01/2001
1Neoplasm Metastasis (Metastasis)
01/2000
1Paraplegia (Spastic Paraplegia)
01/2000

Drug/Important Bio-Agent (IBA)

4Somatostatin Receptors (Somatostatin Receptor)IBA
12/2008 - 06/2001
4(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
12/2008 - 04/2001
4DOTA-Tyr(3)- 90Y-octreotideIBA
01/2004 - 01/2000
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2001 - 01/2000
2Octreotide (Sandostatin)FDA LinkGeneric
06/2001 - 01/2000
1RadiopharmaceuticalsIBA
01/2003
1HormonesIBA
01/2003
1Monoclonal AntibodiesIBA
01/2003
1SteroidsIBA
04/2002
1Morphine (MS Contin)FDA LinkGeneric
07/2001
1medullary Thyroid cancerIBA
06/2001
1somatostatin receptor type 1IBA
06/2001
1YttriumIBA
04/2001
1CreatinineIBA
04/2001

Therapy/Procedure

2Radiotherapy
01/2004 - 04/2001
1Brachytherapy
04/2002
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
07/2001
1Angioplasty (Angioplasty, Transluminal)
07/2001
1Early Ambulation
01/2001